Physician profile
Nando Visvalingam
NPI 1386601862
$1,668.99
in general payments reported to CMS, 2019-2025
17 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2021: $383 · 2022: $225 · 2023: $272 · 2024: $309 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $645 · Education: $35.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.21 |
| Education | $35.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $275.90 | 2021-2023 | Vumerity |
| Genzyme Corporation | $142.78 | 2019-2021 | |
| Amgen INC. | $130.58 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.00 | 2022 | |
| Alexion Pharmaceuticals, INC. | $102.21 | 2024 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $101.61 | 2019 | |
| Amneal Pharmaceuticals LLC | $100.29 | 2025 | Crexont |
| Ucb, INC. | $95.26 | 2019 | |
| Lundbeck LLC | $91.67 | 2024 | Vyepti |
| Abbott Laboratories | $90.34 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $84.73 | 2021 | |
| Genentech, INC. | $73.30 | 2023 | Ocrevus |
| Sk Life Science, INC. | $62.50 | 2023 | Xcopri |
| Eisai INC. | $57.66 | 2024 | |
| Lilly USA, LLC | $57.58 | 2024 | Kisunla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $41.63 | 2021 | |
| Argenx US, INC. | $35.95 | 2023 | Vyvgart |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nando Visvalingam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.